Progesterone receptor membrane component 1/Sigma-2 receptor associates with MAP1LC3B and promotes autophagy

References

• Kimmelman AC. The dynamic nature of autophagy in cancer. Genes Dev 2011; 25:1999 - 2010; http://dx.doi.org/10.1101/gad.17558811; PMID: 21979913
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132:27 - 42; http://dx.doi.org/10.1016/j.cell.2007.12.018; PMID: 18191218
   PubMed Web of Science ®Google Scholar
• Kirkin V, McEwan DG, Novak I, Dikic I. A role for ubiquitin in selective autophagy. Mol Cell 2009; 34:259 - 69; http://dx.doi.org/10.1016/j.molcel.2009.04.026; PMID: 19450525
   PubMed Web of Science ®Google Scholar
• Kirisako T, Ichimura Y, Okada H, Kabeya Y, Mizushima N, Yoshimori T, Ohsumi M, Takao T, Noda T, Ohsumi Y. The reversible modification regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway. J Cell Biol 2000; 151:263 - 76; http://dx.doi.org/10.1083/jcb.151.2.263; PMID: 11038174
   PubMed Web of Science ®Google Scholar
• Ichimura Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, Ishihara N, Mizushima N, Tanida I, Kominami E, Ohsumi M, et al. A ubiquitin-like system mediates protein lipidation. Nature 2000; 408:488 - 92; http://dx.doi.org/10.1038/35044114; PMID: 11100732
   PubMed Web of Science ®Google Scholar
• Behrends C, Sowa ME, Gygi SP, Harper JW. Network organization of the human autophagy system. Nature 2010; 466:68 - 76; http://dx.doi.org/10.1038/nature09204; PMID: 20562859
   PubMed Web of Science ®Google Scholar
• Funderburk SF, Wang QJ, Yue Z. The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond. Trends Cell Biol 2010; 20:355 - 62; http://dx.doi.org/10.1016/j.tcb.2010.03.002; PMID: 20356743
   PubMed Web of Science ®Google Scholar
• Thoresen SB, Pedersen NM, Liestøl K, Stenmark H. A phosphatidylinositol 3-kinase class III sub-complex containing VPS15, VPS34, Beclin 1, UVRAG and BIF-1 regulates cytokinesis and degradative endocytic traffic. Exp Cell Res 2010; 316:3368 - 78; http://dx.doi.org/10.1016/j.yexcr.2010.07.008; PMID: 20643123
   PubMed Web of Science ®Google Scholar
• Liang C, Lee JS, Inn KS, Gack MU, Li Q, Roberts EA, Vergne I, Deretic V, Feng P, Akazawa C, et al. Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Nat Cell Biol 2008; 10:776 - 87; http://dx.doi.org/10.1038/ncb1740; PMID: 18552835
   PubMed Web of Science ®Google Scholar
• Xu J, Zeng C, Chu W, Pan F, Rothfuss JM, Zhang F, Tu Z, Zhou D, Zeng D, Vangveravong S, et al. Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site. Nat Commun 2011; 2:380; http://dx.doi.org/10.1038/ncomms1386; PMID: 21730960
   PubMed Web of Science ®Google Scholar
• Mifsud W, Bateman A. Membrane-bound progesterone receptors contain a cytochrome b5-like ligand-binding domain. Genome Biol 2002; 3:H0068; http://dx.doi.org/10.1186/gb-2002-3-12-research0068; PMID: 12537557
   PubMedGoogle Scholar
• Min L, Strushkevich NV, Harnastai IN, Iwamoto H, Gilep AA, Takemori H, Usanov SA, Nonaka Y, Hori H, Vinson GP, et al. Molecular identification of adrenal inner zone antigen as a heme-binding protein. FEBS J 2005; 272:5832 - 43; http://dx.doi.org/10.1111/j.1742-4658.2005.04977.x; PMID: 16279947
   PubMed Web of Science ®Google Scholar
• Rohe HJ, Ahmed IS, Twist KE, Craven RJ. PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding. Pharmacol Ther 2009; 121:14 - 9; http://dx.doi.org/10.1016/j.pharmthera.2008.09.006; PMID: 18992768
   PubMed Web of Science ®Google Scholar
• Falkenstein E, Meyer C, Eisen C, Scriba PC, Wehling M. Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem Biophys Res Commun 1996; 229:86 - 9; http://dx.doi.org/10.1006/bbrc.1996.1761; PMID: 8954087
   PubMed Web of Science ®Google Scholar
• Selmin O, Lucier GW, Clark GC, Tritscher AM, Vanden Heuvel JP, Gastel JA, Walker NJ, Sutter TR, Bell DA. Isolation and characterization of a novel gene induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis 1996; 17:2609 - 15; http://dx.doi.org/10.1093/carcin/17.12.2609; PMID: 9006096
   PubMed Web of Science ®Google Scholar
• Gerdes D, Wehling M, Leube B, Falkenstein E. Cloning and tissue expression of two putative steroid membrane receptors. Biol Chem 1998; 379:907 - 11; PMID: 9705155
   PubMed Web of Science ®Google Scholar
• Mir SU, Ahmed IS, Arnold S, Craven RJ. Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients. Int J Cancer 2012; 131:E1 - 9; http://dx.doi.org/10.1002/ijc.26432; PMID: 21918976
   PubMed Web of Science ®Google Scholar
• Peluso JJ, Liu X, Saunders MM, Claffey KP, Phoenix K. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1. J Clin Endocrinol Metab 2008; 93:1592 - 9; http://dx.doi.org/10.1210/jc.2007-2771; PMID: 18319313
   PubMed Web of Science ®Google Scholar
• Hou C, Tu Z, Mach R, Kung HF, Kung MP. Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker. Nucl Med Biol 2006; 33:203 - 9; http://dx.doi.org/10.1016/j.nucmedbio.2005.10.001; PMID: 16546674
   PubMed Web of Science ®Google Scholar
• Wheeler KT, Wang LM, Wallen CA, Childers SR, Cline JM, Keng PC, Mach RH. Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br J Cancer 2000; 82:1223 - 32; http://dx.doi.org/10.1054/bjoc.1999.1067; PMID: 10735510
   PubMed Web of Science ®Google Scholar
• Hornick JR, Xu J, Vangveravong S, Tu Z, Mitchem JB, Spitzer D, Goedegebuure P, Mach RH, Hawkins WG. The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine. Mol Cancer 2010; 9:298; http://dx.doi.org/10.1186/1476-4598-9-298; PMID: 21092190
   PubMed Web of Science ®Google Scholar
• Thompson AM, Reddi AR, Shi X, Goldbeck RA, Moenne-Loccoz P, Gibney BR, et al. Measurement of the Heme Affinity for Yeast Dap1p, and Its Importance in Cellular Function. Biochem 2007.
   Google Scholar
• Hughes AL, Powell DW, Bard M, Eckstein J, Barbuch R, Link AJ, Espenshade PJ. Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab 2007; 5:143 - 9; http://dx.doi.org/10.1016/j.cmet.2006.12.009; PMID: 17276356
   PubMed Web of Science ®Google Scholar
• Crudden G, Chitti RE, Craven RJ. Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs. J Pharmacol Exp Ther 2006; 316:448 - 55; http://dx.doi.org/10.1124/jpet.105.094631; PMID: 16234411
   PubMed Web of Science ®Google Scholar
• Hand RA, Jia N, Bard M, Craven RJ. Saccharomyces cerevisiae Dap1p, a novel DNA damage response protein related to the mammalian membrane-associated progesterone receptor. Eukaryot Cell 2003; 2:306 - 17; http://dx.doi.org/10.1128/EC.2.2.306-317.2003; PMID: 12684380
   PubMed Web of Science ®Google Scholar
• Mallory JC, Crudden G, Johnson BL, Mo C, Pierson CA, Bard M, Craven RJ. Dap1p, a heme-binding protein that regulates the cytochrome P450 protein Erg11p/Cyp51p in Saccharomyces cerevisiae. Mol Cell Biol 2005; 25:1669 - 79; http://dx.doi.org/10.1128/MCB.25.5.1669-1679.2005; PMID: 15713626
   PubMed Web of Science ®Google Scholar
• Craven RJ, Mallory JC, Hand RA. Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11/Cyp51. J Biol Chem 2007; 282:36543 - 51; http://dx.doi.org/10.1074/jbc.M706770200; PMID: 17954932
   PubMed Web of Science ®Google Scholar
• Neubauer H, Clare SE, Wozny W, Schwall GP, Poznanovic S, Stegmann W, Vogel U, Sotlar K, Wallwiener D, Kurek R, et al. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1. Breast Cancer Res 2008; 10:R85; http://dx.doi.org/10.1186/bcr2155; PMID: 18922159
   PubMed Web of Science ®Google Scholar
• Ahmed IS, Rohe HJ, Twist KE, Mattingly MN, Craven RJ. Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule. J Pharmacol Exp Ther 2010; 333:564 - 73; http://dx.doi.org/10.1124/jpet.109.164210; PMID: 20164297
   PubMed Web of Science ®Google Scholar
• Hand RA, Craven RJ. Hpr6.6 protein mediates cell death from oxidative damage in MCF-7 human breast cancer cells. J Cell Biochem 2003; 90:534 - 47; http://dx.doi.org/10.1002/jcb.10648; PMID: 14523988
   PubMed Web of Science ®Google Scholar
• Ahmed IS, Rohe HJ, Twist KE, Craven RJ. Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity. J Biol Chem 2010; 285:24775 - 82; http://dx.doi.org/10.1074/jbc.M110.134585; PMID: 20538600
   PubMed Web of Science ®Google Scholar
• Peluso JJ, Liu X, Gawkowska A, Lodde V, Wu CA. Progesterone inhibits apoptosis in part by PGRMC1-regulated gene expression. Mol Cell Endocrinol 2010; 320:153 - 61; http://dx.doi.org/10.1016/j.mce.2010.02.005; PMID: 20144686
   PubMed Web of Science ®Google Scholar
• Peluso JJ, Pappalardo A, Losel R, Wehling M. Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone’s antiapoptotic action. Endocrinology 2006; 147:3133 - 40; http://dx.doi.org/10.1210/en.2006-0114; PMID: 16513825
   PubMed Web of Science ®Google Scholar
• Peluso JJ, Romak J, Liu X. Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone’s antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations. Endocrinology 2008; 149:534 - 43; http://dx.doi.org/10.1210/en.2007-1050; PMID: 17991724
   PubMed Web of Science ®Google Scholar
• Kashiwagi H, McDunn JE, Simon PO Jr., Goedegebuure PS, Vangveravong S, Chang K, Hotchkiss RS, Mach RH, Hawkins WG. Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma. J Transl Med 2009; 7:24; http://dx.doi.org/10.1186/1479-5876-7-24; PMID: 19323815
   PubMed Web of Science ®Google Scholar
• Ostenfeld MS, Fehrenbacher N, Høyer-Hansen M, Thomsen C, Farkas T, Jäättelä M. Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress. Cancer Res 2005; 65:8975 - 83; http://dx.doi.org/10.1158/0008-5472.CAN-05-0269; PMID: 16204071
   PubMed Web of Science ®Google Scholar
• Ostenfeld MS, Høyer-Hansen M, Bastholm L, Fehrenbacher N, Olsen OD, Groth-Pedersen L, Puustinen P, Kirkegaard-Sørensen T, Nylandsted J, Farkas T, et al. Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation. Autophagy 2008; 4:487 - 99; PMID: 18305408
   PubMed Web of Science ®Google Scholar
• Groth-Pedersen L, Ostenfeld MS, Høyer-Hansen M, Nylandsted J, Jäättelä M. Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine. Cancer Res 2007; 67:2217 - 25; http://dx.doi.org/10.1158/0008-5472.CAN-06-3520; PMID: 17332352
   PubMed Web of Science ®Google Scholar
• Brent PJ, Pang GT. Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture. Eur J Pharmacol 1995; 278:151 - 60; http://dx.doi.org/10.1016/0014-2999(95)00115-2; PMID: 7671999
   PubMed Web of Science ®Google Scholar
• Crawford KW, Bowen WD. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res 2002; 62:313 - 22; PMID: 11782394
   PubMed Web of Science ®Google Scholar
• Spitzer D, Simon PO Jr., Kashiwagi H, Xu J, Zeng C, Vangveravong S, Zhou D, Chang K, McDunn JE, Hornick JR, et al. Use of multifunctional sigma-2 receptor ligand conjugates to trigger cancer-selective cell death signaling. Cancer Res 2012; 72:201 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-11-1354; PMID: 22065721
   PubMed Web of Science ®Google Scholar
• Yoshitani N, Satou K, Saito K, Suzuki S, Hatanaka H, Seki M, Shinozaki K, Hirota H, Yokoyama S. A structure-based strategy for discovery of small ligands binding to functionally unknown proteins: combination of in silico screening and surface plasmon resonance measurements. Proteomics 2005; 5:1472 - 80; http://dx.doi.org/10.1002/pmic.200401032; PMID: 15798990
   PubMed Web of Science ®Google Scholar
• Park J, Chung S, An H, Kim J, Seo J, Kim DH, Yoon SY. Haloperidol and clozapine block formation of autophagolysosomes in rat primary neurons. Neuroscience 2012; 209:64 - 73; http://dx.doi.org/10.1016/j.neuroscience.2012.02.035; PMID: 22390943
   PubMed Web of Science ®Google Scholar
• Mo RH, Zaro JL, Ou JH, Shen WC. Effects of Lipofectamine 2000/siRNA complexes on autophagy in hepatoma cells. Mol Biotechnol 2012; 51:1 - 8; http://dx.doi.org/10.1007/s12033-011-9422-6; PMID: 21660602
   PubMed Web of Science ®Google Scholar
• Heitman J, Movva NR, Hall MN. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991; 253:905 - 9; http://dx.doi.org/10.1126/science.1715094; PMID: 1715094
   PubMed Web of Science ®Google Scholar
• Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 1994; 78:35 - 43; http://dx.doi.org/10.1016/0092-8674(94)90570-3; PMID: 7518356
   PubMed Web of Science ®Google Scholar
• Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, Schreiber SL. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994; 369:756 - 8; http://dx.doi.org/10.1038/369756a0; PMID: 8008069
   PubMed Web of Science ®Google Scholar
• Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12:21 - 35; http://dx.doi.org/10.1038/nrm3025; PMID: 21157483
   PubMed Web of Science ®Google Scholar
• van Veelen W, Korsse SE, van de Laar L, Peppelenbosch MP. The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling. Oncogene 2011; 30:2289 - 303; http://dx.doi.org/10.1038/onc.2010.630; PMID: 21258412
   PubMed Web of Science ®Google Scholar
• Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 2003; 13:1259 - 68; http://dx.doi.org/10.1016/S0960-9822(03)00506-2; PMID: 12906785
   PubMed Web of Science ®Google Scholar
• Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci U S A 2002; 99:13571 - 6; http://dx.doi.org/10.1073/pnas.202476899; PMID: 12271141
   PubMed Web of Science ®Google Scholar
• Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003; 115:577 - 90; http://dx.doi.org/10.1016/S0092-8674(03)00929-2; PMID: 14651849
   PubMed Web of Science ®Google Scholar
• Mann SS, Hammarback JA. Molecular characterization of light chain 3. A microtubule binding subunit of MAP1A and MAP1B. J Biol Chem 1994; 269:11492 - 7; PMID: 7908909
   PubMed Web of Science ®Google Scholar
• Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Øvervatn A, Bjørkøy G, Johansen T. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007; 282:24131 - 45; http://dx.doi.org/10.1074/jbc.M702824200; PMID: 17580304
   PubMed Web of Science ®Google Scholar
• Tsukada M, Ohsumi Y. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett 1993; 333:169 - 74; http://dx.doi.org/10.1016/0014-5793(93)80398-E; PMID: 8224160
   PubMed Web of Science ®Google Scholar
• Noda T, Ohsumi Y. Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J Biol Chem 1998; 273:3963 - 6; http://dx.doi.org/10.1074/jbc.273.7.3963; PMID: 9461583
   PubMed Web of Science ®Google Scholar
• Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y, Reichling LJ, Sim T, Sabatini DM, Gray NS. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 2009; 284:8023 - 32; http://dx.doi.org/10.1074/jbc.M900301200; PMID: 19150980
   PubMed Web of Science ®Google Scholar
• Kamada Y, Funakoshi T, Shintani T, Nagano K, Ohsumi M, Ohsumi Y. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J Cell Biol 2000; 150:1507 - 13; http://dx.doi.org/10.1083/jcb.150.6.1507; PMID: 10995454
   PubMed Web of Science ®Google Scholar
• Alers S, Löffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol 2012; 32:2 - 11; http://dx.doi.org/10.1128/MCB.06159-11; PMID: 22025673
   PubMed Web of Science ®Google Scholar
• Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007; 8:774 - 85; http://dx.doi.org/10.1038/nrm2249; PMID: 17712357
   PubMed Web of Science ®Google Scholar
• Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 2011; 13:1016 - 23; http://dx.doi.org/10.1038/ncb2329; PMID: 21892142
   PubMed Web of Science ®Google Scholar
• Inoki K, Li Y, Xu T, Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 2003; 17:1829 - 34; http://dx.doi.org/10.1101/gad.1110003; PMID: 12869586
   PubMed Web of Science ®Google Scholar
• Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H, Kozma SC, Hafen E, Bos JL, Thomas G. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 2003; 11:1457 - 66; http://dx.doi.org/10.1016/S1097-2765(03)00220-X; PMID: 12820960
   PubMed Web of Science ®Google Scholar
• Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, Pan D. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 2003; 5:578 - 81; http://dx.doi.org/10.1038/ncb999; PMID: 12771962
   PubMed Web of Science ®Google Scholar
• Li DD, Wang LL, Deng R, Tang J, Shen Y, Guo JF, Wang Y, Xia LP, Feng GK, Liu QQ, et al. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene 2009; 28:886 - 98; http://dx.doi.org/10.1038/onc.2008.441; PMID: 19060920
   PubMed Web of Science ®Google Scholar
• Lorin S, Borges A, Ribeiro Dos Santos L, Souquère S, Pierron G, Ryan KM, Codogno P, Djavaheri-Mergny M. c-Jun NH2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated Ewing sarcoma cells. Cancer Res 2009; 69:6924 - 31; http://dx.doi.org/10.1158/0008-5472.CAN-09-1270; PMID: 19706754
   PubMed Web of Science ®Google Scholar
• Mir SU, Jin L, Craven RJ. Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1. J Biol Chem 2012; 287:14494 - 501; http://dx.doi.org/10.1074/jbc.M111.324921; PMID: 22418433
   PubMed Web of Science ®Google Scholar
• Sambade M, Alba M, Smardon AM, West RW, Kane PM. A genomic screen for yeast vacuolar membrane ATPase mutants. Genetics 2005; 170:1539 - 51; http://dx.doi.org/10.1534/genetics.105.042812; PMID: 15937126
   PubMed Web of Science ®Google Scholar
• Vadlamudi RK, Joung I, Strominger JL, Shin J. p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. J Biol Chem 1996; 271:20235 - 7; http://dx.doi.org/10.1074/jbc.271.34.20235; PMID: 8702753
   PubMed Web of Science ®Google Scholar
• Hornick JR, Vangveravong S, Spitzer D, Abate C, Berardi F, Goedegebuure P, Mach RH, Hawkins WG. Lysosomal membrane permeabilization is an early event in Sigma-2 receptor ligand mediated cell death in pancreatic cancer. J Exp Clin Cancer Res 2012; 31:41; http://dx.doi.org/10.1186/1756-9966-31-41; PMID: 22551149
   PubMed Web of Science ®Google Scholar
• Wei Z, Mousseau DD, Dai Y, Cao X, Li XM. Haloperidol induces apoptosis via the sigma2 receptor system and Bcl-XS. Pharmacogenomics J 2006; 6:279 - 88; PMID: 16462815
   PubMed Web of Science ®Google Scholar
• Bowen WD. Sigma receptors: recent advances and new clinical potentials. Pharm Acta Helv 2000; 74:211 - 8; http://dx.doi.org/10.1016/S0031-6865(99)00034-5; PMID: 10812960
   PubMedGoogle Scholar
• Monassier L, Manoury B, Bellocq C, Weissenburger J, Greney H, Zimmermann D, Ehrhardt JD, Jaillon P, Baró I, Bousquet P. sigma(2)-receptor ligand-mediated inhibition of inwardly rectifying K(+) channels in the heart. J Pharmacol Exp Ther 2007; 322:341 - 50; http://dx.doi.org/10.1124/jpet.107.122044; PMID: 17460149
   PubMed Web of Science ®Google Scholar